Who should not take GLP-1s GLP-1s in all forms are unsuitable for people who: are pregnant or breastfeeding do not meet the eligibility criteria have a family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) Medical Perspective Patients with needle phobia, a preference for pill-based routines, or good adherence to oral administration guidelines may be better suited to oral GLP-1 formulations like semaglutide (Rybelsus, Wegovy), which can enhance treatment acceptance and potentially offer strong glycemic or weight control
Elevated MDA levels and reduced SOD and GSH indicate heightened oxidative stress
Figure 1 Table 2 Change in Gastrointestinal Symptom Rating Scale
NICE guidelines recommend that patients receiving pharmacological treatment for obesity should have access to ongoing support, including dietary advice
These drugs are designed to mimic the action of a natural hormone in our bodies known as glucagon-like peptide-1 (GLP-1)
Compounded medicines are individually made by compounding pharmacies when a drug isn't commercially available, like when the patient is allergic to an ingredient or there's a shortage of the medicine